Lingfei Xu

CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice

Lingfei Xu, Thomas M. Daly, Cuihua Gao et al. · Human Gene Therapy · 2001 · 171 citations

Aav Vector, Immunology, Viral Pathogenesis +20

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs

Katherine P. Ponder, John R. Melniczek, Lingfei Xu et al. · Proceedings of the National Academy of Sciences · 2002 · 169 citations · Full text

Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B

Lingfei Xu, Cuihua Gao, Mark S. Sands et al. · Blood · 2003 · 101 citations · Full text

Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice

Yuli Liu, Lingfei Xu, Anne K. Hennig et al. · Molecular Therapy · 2004 · 85 citations · Full text

Sclerostin, In Vivo Gene Therapy, Eye Disease +19

Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy

Lingfei Xu, Timothy C. Nichols, Rita Sarkar et al. · Proceedings of the National Academy of Sciences · 2005 · 69 citations · Full text